Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
de research portal van de Rijksuniversiteit Groningen Startpagina
Help en veelgestelde vragen
English
Nederlands
Startpagina
Profielen
Onderzoekseenheden
Onderzoeksoutput
Activiteiten
Datasets
Pers/Media
Projecten
Prijzen
Zoeken op expertise, naam of affiliatie
Bekijk Scopus-profiel
Edwin Bremer
prof. dr.
Faculteit Medische Wetenschappen/UMCG
,
Onco-Immunology (O-I)
https://orcid.org/0000-0002-0325-7376
Overzicht
Vingerafdruk
Netwerk
Onderzoeksoutput
(102)
Activiteiten
(9)
Datasets
(8)
Pers/Media
(11)
Prijzen
(5)
Soortgelijke profielen
(10)
Begeleid werk
(14)
Begeleid werk
Onderzoeksoutput per jaar
Begeleid werk per jaar
Onderzoekersresultaten
14 resultaten
Publicatiejaar, Titel
(aflopend)
Publicatiejaar, Titel
(oplopend)
Titel
Type
Zoekresultaten
2025
Exploring novel therapeutic approaches for the treatment of hematological malignancies: a focus on autophagy and immunotherapy
Visser, N.
,
2025
, [Groningen]:
University of Groningen
.
267 blz.
Onderzoeksoutput
Open Access
Bestand
Novel Therapeutics
100%
Hematological Malignancies
100%
Autophagy
100%
Immunotherapy
100%
Hematologic Malignancy
100%
8
Downloads (Pure)
Multifaceted approaches to tumor microenvironment modulation and immune checkpoint targeting
Melo Gallegos, V. A.,
2025
, [Groningen]:
University of Groningen
.
211 blz.
Onderzoeksoutput
Open Access
Bestand
Immune Checkpoint
100%
Tumor Microenvironment
100%
Tumor Microenvironment Modulation
100%
Immunocompetent Cell
100%
Immunity
100%
205
Downloads (Pure)
2024
Exploring novel immune checkpoints and targeted delivery strategies for ovarian cancer therapy
Bilemjian, V.,
2024
, [Groningen]:
University of Groningen
.
159 blz.
Onderzoeksoutput
Open Access
Bestand
Immune Checkpoint
100%
Targeted Delivery
100%
Ovarian Cancer Screening
100%
Epithelial Ovarian Cancer
100%
Delivery Strategy
100%
173
Downloads (Pure)
Navigating the path of Cancer Immunotherapeutics: Novel Targets and Innovative Development Tools
Álvarez Freile, J.
,
2024
, [Groningen]:
University of Groningen
.
190 blz.
Onderzoeksoutput
Open Access
Bestand
Immune Checkpoint Inhibitors
100%
Immune Checkpoint
100%
CD24
100%
Development Tools
100%
Innovative Development
100%
531
Downloads (Pure)
Towards improving cancer immunotherapy: development of novel antibody-based therapeutics and drug delivery systems
Nelemans, L. C.,
2024
, [Groningen]:
University of Groningen
.
171 blz.
Onderzoeksoutput
Open Access
Bestand
Malignant Neoplasm
100%
Drug Delivery System
100%
Immunotherapy
100%
Cancer Immunotherapy
100%
Nanoparticle
100%
66
Downloads (Pure)
2023
Advancing Cancer Immunotherapy with Nanomedicine
Choukrani, G.,
2023
, [Groningen]:
University of Groningen
.
207 blz.
Onderzoeksoutput
Open Access
Bestand
T Cell Activation
100%
Cancer Immunotherapy
100%
Immunoglobulin Domain
100%
Malignant Neoplasm
100%
Immunotherapy
100%
806
Downloads (Pure)
Novel T cell biomarkers and the development of immunotherapeutic anti-tumor strategies
Vlaming, M.,
2023
, [Groningen]:
University of Groningen
.
273 blz.
Onderzoeksoutput
Open Access
Bestand
T Cells
100%
Cancer Types
100%
Immunotherapeutics
100%
Antitumor
100%
Cellular Biomarkers
100%
563
Downloads (Pure)
Towards personalized cancer management: diagnosis and (immuno)therapy
Lin, Y.,
2023
, [Groningen]:
University of Groningen
.
239 blz.
Onderzoeksoutput
Open Access
Bestand
Macrophage
100%
Intravenous Immunoglobulin
100%
Trastuzumab
100%
T Cell
50%
RNA
50%
405
Downloads (Pure)
2022
Innate immune checkpoint inhibitors for treatment of Diffuse Large B-cell Lymphoma
Bouwstra, R.,
2022
, [Groningen]:
University of Groningen
.
219 blz.
Onderzoeksoutput
Open Access
Bestand
Immune Checkpoint Inhibitors
100%
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Innate Immune Checkpoint
100%
B Cell
100%
Immune Checkpoints
100%
1170
Downloads (Pure)
2017
Novel antibody-based drugs for PD-L1 and TRAIL-R targeted cancer immunotherapy
Hendriks, D.,
2017
, [Groningen]:
Rijksuniversiteit Groningen
.
163 blz.
Onderzoeksoutput
Open Access
Bestand
TRAIL
100%
Cancer Immunotherapy
100%
PD-L1
100%
Malignant Neoplasm
100%
Immunotherapy
100%
4177
Downloads (Pure)
Towards novel cancer (immuno)therapy using TRAIL and Galectin-9
Wiersma, V. R.
,
2017
, [Groningen]:
Rijksuniversiteit Groningen
.
184 blz.
Onderzoeksoutput
Open Access
Bestand
Cancer Cell
100%
Galectin
100%
TRAIL
100%
Cancer Immunotherapy
100%
Malignant Neoplasm
100%
1554
Downloads (Pure)
2016
TNF receptor superfamily-based targeted cancer immunotherapy
He, Y.,
2016
, [Groningen]:
University of Groningen
.
152 blz.
Onderzoeksoutput
Open Access
Bestand
Cancer Cell
100%
Cancer Immunotherapy
100%
Tumor Necrosis Factor Receptor
100%
Malignant Neoplasm
100%
Immunotherapy
100%
1482
Downloads (Pure)
2013
Immunologic aspects of ovarian cancer
Gooden, M. J. M.,
2013
, Groningen:
s.n.
.
175 blz.
Onderzoeksoutput
Open Access
Bestand
3225
Downloads (Pure)
2012
Targeted delivery of TRAIL for immunotherapy of ovarian cancer
Bruyn, M. D.
,
2012
, Groningen:
s.n.
.
173 blz.
Onderzoeksoutput
Open Access
Bestand
396
Downloads (Pure)